Navigation Links
New Appointments, and Share Price Movements - Research Report on Humana, Illumina, Edwards Lifesciences, Aegerion Pharmaceuticals, and CytRx
Date:12/24/2013

NEW YORK, December 24, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Humana Inc. (NYSE: HUM), Illumina Inc. (NASDAQ: ILMN), Edwards Lifesciences Corp. (NYSE: EW), Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) and CytRx Corporation (NASDAQ: CYTR). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Humana Inc. Research Report

On December 16, 2013, Humana Inc. (Humana) announced that Kurt J. Hilzinger, currently serving as Lead Director, will become the Chairman of the Board of the Company after the retirement of Michael B. McCallister, effective December 31, 2013. Humana stated that McCallister has been the Chairman of the Board since his appointment to that position in August 2010. McCallister commented, "Kurt's role as Lead Director has prepared him well to lead Humana's Board of Directors upon my retirement. I have full confidence that he will continue to ensure corporate governance and accountability to our shareholders remain at the forefront for our directors." The Full Research Report on Humana Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/496b_HUM

--

Illumina Inc. Research Report

On December 19, 2013, Illumina Inc.'s (Illumina) stock declined 1.06%, ending the day at $103.51. Over the previous three trading sessions, shares of Illumina increased 0.89%, compared to the Nasdaq Composite, which advanced 0.71% during the same period. The Full Research Report on Illumina Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/3cf2_ILMN

--

Edwards Lifesciences Corp. Research Report

On December 19, 2013, Edwards Lifesciences Corp.'s (Edwards Lifesciences) stock increased 0.35%, ending the day at $63.97. Over the previous three trading sessions, shares of Edwards Lifesciences increased 1.80%, compared to the Dow Jones Industrial Average, which gained 1.85% during the same period. The Full Research Report on Edwards Lifesciences Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/48b8_EW

--

Aegerion Pharmaceuticals, Inc. Research Report

On December 19, 2013, Aegerion Pharmaceuticals, Inc.'s (Aegerion Pharmaceuticals) stock declined 1.02%, ending the day at $64.33. Over the previous three trading sessions, shares of Aegerion Pharmaceuticals declined 2.90%, compared to the Nasdaq Composite, which increased 0.71% during the same period. The Full Research Report on Aegerion Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/a3f6_AEGR

--

CytRx Corporation Research Report

On December 19, 2013, CytRx Corporation's (CytRx) stock declined 6.15%, ending the day at $4.88. Over the previous three trading sessions, shares of CytRx declined 6.51%, compared to the Nasdaq Composite, which increased 0.71% during the same period. The Full Research Report on CytRx Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/1869_CYTR

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

http://AnalystsCorner.com

 


'/>"/>
SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Financial Results, Appointments, Earnings Conferences, and Partnerships - Research Report on New Oriental Education & Technology, Acacia Research, DeVry, Capella Education, and Qiagen NV
2. Partnerships, Appointments, New Products, Public Offerings, and Agreements - Research Report on Questcor Pharmaceuticals, Hologic, IDEXX, Endologix, and Healthways
3. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
4. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
5. Telemedicine Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
6. Heska Announces Quarterly Dividend of $0.10 Per Share
7. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
8. OncoSec Medical Issues Letter to Shareholders
9. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
10. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
11. Omnyx Share Their Insight on Agile Software Development for Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 CANTEL MEDICAL CORP. (NYSE: CMD ... $0.45 per diluted share, on a 22.1% increase in sales ... 31, 2016. This compares with net income of $14,254,000, or ... first quarter ended October 31, 2015. Non-GAAP ... 31, 2016 to $21,323,000, or $0.51 per diluted share, compared ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte ... the Genome Institute of Singapore (GIS) ... joint venture between Novogene and AITbiotech – will establish a ... Singapore .   The new centre will ...
(Date:12/7/2016)... --  IQuity, Inc., a specialty diagnostic technology ... has been appointed to its Board of ... experience as CEO, COO, and Board Director for ... the molecular, clinical diagnostic, and medical device industries. ... within the pharmaceutical industry. His operational and commercial ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, N.Y., ... for adherence to the highest standards of trauma, maternity, cancer and chronic obstructive ... president and CEO, Dr. Daniel Messina. , Among the recognitions, the American College ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the Affordable Care Act. Dr. Botelho advocates for the mass media launching of ... gives people ongoing opportunities to share their unfortunate experiences; such a movement can ...
(Date:12/8/2016)... AR (PRWEB) , ... December 08, 2016 , ... ... insurance and financial planning services from offices headquartered in Little Rock, has initiated ... Pantry. , According to the National Foundation to End Senior Hunger, Arkansas ranks ...
Breaking Medicine News(10 mins):